T0	Participants 41 155	patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.
T1	Participants 513 582	Nineteen patients with extremity melanoma (n = 16) or sarcoma (n = 3)